B. O. Amorim, C. Hamani, E. Ferreira, M. F. Miranda, M. J. Fernandes et al., Effects of A1 receptor agonist/antagonist on spontaneous seizures in pilocarpine-induced epileptic rats, Epilepsy Behav, vol.61, pp.168-173, 2016.

F. Angelatou, O. Pagonopoulou, T. Maraziotis, A. Olivier, J. G. Villemeure et al., Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study, Neurosci Lett, vol.163, issue.1, pp.11-14, 1993.

B. Ault, M. A. Olney, J. L. Joyner, C. E. Boyer, M. A. Notrica et al., Pro-convulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy, Brain Res, vol.426, issue.1, pp.93-102, 1987.

M. Avoli, D. 'antuono, M. Louvel, J. Kohling, R. Biagini et al., Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro, Prog Neurobiol, vol.68, issue.3, pp.167-207, 2002.

M. D. Baxi and J. K. Vishwanatha, Diadenosine polyphosphatestheir biological and pharmacological significance, J Pharmacol Toxicol Methods, vol.33, issue.3, pp.121-128, 1995.

D. Boison, Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies, Neuroscientist, vol.11, issue.1, pp.25-36, 2005.

D. Boison, Adenosine kinase, epilepsy and stroke: mechanisms and therapies, Trends Pharmacol Sci, vol.27, issue.12, pp.652-658, 2006.

D. Boison, Adenosine dysfunction in epilepsy, Glia, vol.60, issue.8, pp.1234-1243, 2012.

P. A. Borea, S. Gessi, S. Merighi, and K. Varani, Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?, Trends Pharmacol Sci, vol.37, issue.6, pp.419-434, 2016.

D. Brambilla, D. Chapman, and R. Greene, Adenosine mediation of presynaptic feedback inhibition of glutamate release, Neuron, vol.46, issue.2, pp.275-283, 2005.

J. M. Brundege and T. V. Dunwiddie, Metabolic regulation of endogenous adenosine release from single neurons, Neuroreport, vol.9, issue.13, pp.3007-3011, 1998.

F. Ciruela, Adenosine receptors, Biochim Biophys Acta, vol.1808, issue.5, pp.1231-1232, 2011.

R. A. Cunha, Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors, Neurochem Int, vol.38, issue.2, pp.107-125, 2001.

R. A. Cunha, B. Johansson, M. D. Constantino, A. M. Sebastiao, and B. B. Fredholm, Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors, Naunyn Schmiedebergs Arch Pharmacol, vol.353, issue.3, pp.261-271, 1996.

R. A. Cunha, A. M. Sebastiao, and J. A. Ribeiro, Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors, J Neurosci, vol.18, issue.6, pp.1987-1995, 1998.

P. Curatolo, R. Bombardieri, and S. Jozwiak, Tuberous sclerosis, Lancet, vol.372, issue.9639, pp.657-668, 2008.

S. M. Delaney, G. M. Blackburn, and J. D. Geiger, Diadenosine polyphosphates inhibit adenosine kinase activity but decrease levels of endogenous adenosine in rat brain, Eur J Pharmacol, vol.332, issue.1, pp.35-42, 1997.

M. Diaz-hernandez, M. F. Pereira, J. Pintor, R. A. Cunha, J. A. Ribeiro et al., Modulation of the rat hippocampal dinucleotide receptor by adenosine receptor activation, J Pharmacol Exp Ther, vol.301, issue.2, pp.441-450, 2002.

T. V. Dunwiddie, L. Diao, and W. R. Proctor, Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus, J Neurosci, vol.17, issue.20, pp.7673-7682, 1997.

T. V. Dunwiddie and S. A. Masino, The role and regulation of adenosine in the central nervous system, Annu Rev Neurosci, vol.24, pp.31-55, 2001.

M. El-yacoubi, C. Ledent, M. Parmentier, J. Costentin, and J. M. Vaugeois, Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazolinduced seizures produced in mice by long-term treatment with caffeine, Neuropharmacology, vol.55, issue.1, pp.35-40, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02185485

M. El-yacoubi, C. Ledent, M. Parmentier, J. Costentin, and J. M. Vaugeois, Adenosine A2A receptor deficient mice are partially resistant to limbic seizures, Naunyn Schmiedebergs Arch Pharmacol, vol.380, issue.3, pp.223-232, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02185491

R. D. Fields, Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling, Semin Cell Dev Biol, vol.22, issue.2, pp.214-219, 2011.

B. B. Fredholm, A. P. Ij, K. A. Jacobson, K. N. Klotz, and J. Linden, International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors, Pharmacol Rev, vol.53, issue.4, pp.527-552, 2001.

S. Gataullina, E. Lemaire, F. Wendling, A. Kaminska, F. Watrin et al., Epilepsy in young Tsc1(+/?) mice exhibits agedependent expression that mimics that of human tuberous sclerosis complex, Epilepsia, vol.57, issue.4, pp.648-659, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01274304

M. Glass, R. L. Faull, J. Y. Bullock, K. Jansen, E. W. Mee et al., Loss of A1 adenosine receptors in human temporal lobe epilepsy, Brain Res, vol.710, issue.1-2, pp.56-68, 1996.

N. Gouder, J. M. Fritschy, and D. Boison, Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy, Epilepsia, vol.44, issue.7, pp.877-885, 2003.

N. Gouder, L. Scheurer, J. M. Fritschy, and D. Boison, Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis, J Neurosci, vol.24, issue.3, pp.692-701, 2004.

H. L. Haas and O. Selbach, Functions of neuronal adenosine receptors, Naunyn Schmiedebergs Arch Pharmacol, vol.362, issue.4-5, pp.375-381, 2000.

N. J. Hargus, C. Jennings, E. Perez-reyes, E. H. Bertram, and M. K. Patel, Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A(1)-receptor activation, Epilepsia, vol.53, issue.1, pp.168-176, 2012.

H. Hibino, A. Inanobe, K. Furutani, S. Murakami, I. Findlay et al., Inwardly rectifying potassium channels: their structure, function, and physiological roles, Physiol Rev, vol.90, issue.1, pp.291-366, 2010.

A. Huber, V. Padrun, N. Deglon, P. Aebischer, H. Mohler et al., Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy, Proc Natl Acad Sci, vol.98, issue.13, pp.7611-7616, 2001.

L. L. Jennings, C. Hao, M. A. Cabrita, M. F. Vickers, S. A. Baldwin et al., Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system, Neuropharmacology, vol.40, issue.5, pp.722-731, 2001.

A. Klishin, N. Lozovaya, J. Pintor, M. T. Miras-portugal, and O. Krishtal, Possible functional role of diadenosine polyphosphates: negative feedback for excitation in hippocampus, Neuroscience, vol.58, issue.2, pp.235-236, 1994.

S. Koizumi, K. Ohsawa, K. Inoue, and S. Kohsaka, Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors, Glia, vol.61, issue.1, pp.47-54, 2013.

I. Kruglikov and R. B. , Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators, Neuron, vol.58, issue.6, pp.911-924, 2008.

E. R. Lazarowski, W. C. Watt, M. J. Stutts, R. C. Boucher, and T. K. Harden, Pharmacological selectivity of the cloned human P2Upurinoceptor: potent activation by diadenosine tetraphosphate, Br J Pharmacol, vol.116, issue.1, pp.1619-1627, 1995.

L. Albasanz, J. L. Martin, and M. , Hyperthermiainduced seizures alter adenosine A1 and A2A receptors and 5'-nucleotidase activity in rat cerebral cortex, J Neurochem, vol.134, issue.3, pp.395-404, 2015.

F. Lesage and M. Lazdunski, Molecular and functional properties of two-pore-domain potassium channels, Am J Physiol Renal Physiol, vol.279, issue.5, pp.793-801, 2000.

N. Li, T. A. Csepe, B. J. Hansen, L. V. Sul, A. Kalyanasundaram et al., Adenosine-induced atrial fibrillation: localized reentrant drivers in lateral right atria due to heterogeneous expression of adenosine A1 receptors and GIRK4 subunits in the human heart, Circulation, vol.134, issue.6, pp.486-498, 2016.

J. S. Lim, R. Gopalappa, S. H. Kim, S. Ramakrishna, M. Lee et al., Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia, Am J Hum Genet, vol.100, issue.3, pp.454-472, 2017.

J. S. Lim, W. I. Kim, H. C. Kang, S. H. Kim, A. H. Park et al., Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy, Nat Med, vol.21, issue.4, pp.395-400, 2015.

L. V. Lopes, R. A. Cunha, and J. A. Ribeiro, Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats, J Neurophysiol, vol.82, issue.6, pp.3196-3203, 1999.

L. V. Lopes, L. Halldner, N. Rebola, B. Johansson, C. Ledent et al., Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice, Br J Pharmacol, vol.141, issue.6, pp.1006-1014, 2004.

D. Lovatt, Q. Xu, W. Liu, T. Takano, N. A. Smith et al., Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity, Proc Natl Acad Sci, vol.109, issue.16, pp.6265-6270, 2012.

N. Lozovaya, S. Gataullina, T. Tsintsadze, V. Tsintsadze, E. Pallesipocachard et al., Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model, Nature Communications, vol.5, p.4563, 2014.

M. Marchi, L. Raiteri, F. Risso, A. Vallarino, A. Bonfanti et al., Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes, Br J Pharmacol, vol.136, issue.3, pp.434-440, 2002.

E. Marsan and S. Baulac, Review: mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy, Neuropathol Appl Neurobiol, vol.44, issue.1, pp.6-17, 2018.

S. S. Mathew, L. Pozzo-miller, and J. J. Hablitz, Kainate modulates presynaptic GABA release from two vesicle pools, J Neurosci, vol.28, issue.3, pp.725-731, 2008.

A. Mathie, A. Veale, and E. L. , Gating of two pore domain potassium channels, J Physiol, vol.588, pp.3149-3156, 2010.

S. Melnik, M. Wright, J. A. Tanner, T. Tsintsadze, V. Tsintsadze et al., Diadenosine polyphosphate analog controls postsynaptic excitation in CA3-CA1, 2006.

, Antiepileptic Mechanisms of AppCH 2 ppA Pons-Bennaceur et al. | 17 synapses via a nitric oxide-dependent mechanism, J Pharmacol Exp Ther, vol.318, issue.2, pp.579-588

X. F. Meng, J. T. Yu, J. H. Song, C. S. Tan, and L. , Role of the mTOR signaling pathway in epilepsy, J Neurol Sci, vol.332, issue.1-2, pp.4-15, 2013.

M. T. Miras-portugal, J. Gualix, J. Mateo, M. Diaz-hernandez, R. Gomez-villafuertes et al., Diadenosine polyphosphates, extracellular function and catabolism, Prog Brain Res, vol.120, pp.397-409, 1999.

R. S. Moller, S. Weckhuysen, M. Chipaux, E. Marsan, V. Taly et al., Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy, Neurol Genet, vol.2, issue.6, p.118, 2016.

S. J. Mustafa, R. R. Morrison, B. Teng, and A. Pelleg, Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology, Handb Exp Pharmacol, vol.193, pp.161-188, 2009.

A. C. Newby, How does dipyridamole elevate extracellular adenosine concentration? Predictions from a threecompartment model of adenosine formation and inactivation, Biochem J, vol.237, issue.3, pp.845-851, 1986.

O. Pagonopoulou, A. Efthimiadou, B. Asimakopoulos, and N. K. Nikolettos, Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches, Neurosci Res, vol.56, issue.1, pp.14-20, 2006.

J. Pintor, M. A. Diaz-rey, and M. Mt, Ap4A and ADPbeta-S binding to P2 purinoceptors present on rat brain synaptic terminals, Br J Pharmacol, vol.108, issue.4, pp.1094-1099, 1993.

J. Pintor, B. F. King, M. T. Miras-portugal, and G. Burnstock, Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors, Br J Pharmacol, vol.119, issue.5, pp.1006-1012, 1996.

J. Pintor and M. T. Miras-portugal, P2 purinergic receptors for diadenosine polyphosphates in the nervous system, Gen Pharmacol, vol.26, issue.2, pp.229-235, 1995.

M. A. Punke, T. Licher, O. Pongs, and P. Friederich, Inhibition of human TREK-1 channels by bupivacaine, Anesth Analg, vol.96, issue.6, pp.1665-1673, 2003.

N. Rebola, J. E. Coelho, A. R. Costenla, L. V. Lopes, A. Parada et al., Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats, Eur J Neurosci, vol.18, issue.4, pp.820-828, 2003.

D. S. Reddy and R. Kuruba, Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions, Int J Mol Sci, vol.14, issue.9, pp.18284-18318, 2013.

R. J. Rodrigues, A. Tome, and R. A. Cunha, ATP as a multi-target danger signal in the brain, Front Neurosci, vol.9, p.148, 2015.

N. Rotermund, S. Winandy, T. Fischer, K. Schulz, T. Fregin et al., Adenosine A1 receptor activates background potassium channels and modulates information processing in olfactory bulb mitral cells, J Physiol, vol.596, issue.4, pp.717-733, 2018.

A. Rubino and G. Burnstock, Possible role of diadenosine polyphosphates as modulators of cardiac sensory-motor neurotransmission in guinea-pigs, J Physiol, vol.495, issue.2, pp.515-523, 1996.

J. B. Schachter, Q. Li, J. L. Boyer, R. A. Nicholas, and T. K. Harden, Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor, Br J Pharmacol, vol.118, issue.1, pp.167-173, 1996.

D. Schmidt and S. C. Schachter, Drug treatment of epilepsy in adults, Br Med J, vol.348, p.254, 2014.

A. K. Sharma, R. E. Waheed, A. Rajput, and S. K. , Pharmacoresistant epilepsy: a current update on non-conventional pharmacological and non-pharmacological interventions, J Epilepsy Res, vol.5, issue.1, pp.1-8, 2015.

H. W. Shin, J. S. Soh, H. Z. Kim, J. Hong, D. H. Woo et al., The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1, J Anesth, vol.28, issue.1, pp.81-86, 2014.

G. R. Siggins and P. Schubert, Adenosine depression of hippocampal neurons in vitro: an intracellular study of dosedependent actions on synaptic and membrane potentials, Neurosci Lett, vol.23, issue.1, pp.55-60, 1981.

D. L. Sodickson and B. P. Bean, Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors, J Neurosci, vol.18, issue.20, pp.8153-8162, 1998.

F. E. Studer, D. E. Fedele, A. Marowsky, C. Schwerdel, K. Wernli et al., Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme, Neuroscience, vol.142, issue.1, pp.125-137, 2006.

T. Takigawa and C. Alzheimer, G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells, J Physiol, vol.517, issue.2, pp.385-390, 1999.

L. O. Trussell and M. B. Jackson, Adenosine-activated potassium conductance in cultured striatal neurons, Proc Natl Acad Sci, vol.82, issue.14, pp.4857-4861, 1985.

D. Tupone, C. J. Madden, and S. F. Morrison, Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat, J Neurosci, vol.33, issue.36, pp.14512-14525, 2013.

K. I. Van-aerde, G. Qi, and D. Feldmeyer, Cell type-specific effects of adenosine on cortical neurons, Cereb Cortex, vol.25, issue.3, pp.772-787, 2015.

M. J. Wall, A. Atterbury, and N. Dale, Control of basal extracellular adenosine concentration in rat cerebellum, J Physiol, vol.582, pp.137-151, 2007.

M. Wall and N. Dale, Activity-dependent release of adenosine: a critical re-evaluation of mechanism, Curr Neuropharmacol, vol.6, issue.4, pp.329-337, 2008.

M. J. Wall and M. Richardson, Localized adenosine signaling provides fine-tuned negative feedback over a wide dynamic range of neocortical network activities, J Neurophysiol, vol.113, issue.3, pp.871-882, 2015.

J. L. Ward, A. Sherali, Z. P. Mo, and C. M. Tse, Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine, J Biol Chem, vol.275, issue.12, pp.8375-8381, 2000.

S. S. Wildman, S. G. Brown, B. F. King, and G. Burnstock, Selectivity of diadenosine polyphosphates for rat P2X receptor subunits, Eur J Pharmacol, vol.367, issue.1, pp.119-123, 1999.

M. Yamada, A. Inanobe, and Y. Kurachi, G protein regulation of potassium ion channels, Pharmacol Rev, vol.50, issue.4, pp.723-760, 1998.

K. Yamashiro and M. Morita, Novel aspects of extracellular adenosine dynamics revealed by adenosine sensor cells, Neural Regen Res, vol.12, issue.6, pp.881-885, 2017.

L. H. Zeng, N. R. Rensing, and M. Wong, The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy, J Neurosci, vol.29, issue.21, pp.6964-6972, 2009.

P. Zhang, N. M. Bannon, V. Ilin, M. Volgushev, and M. Chistiakova, Adenosine effects on inhibitory synaptic transmission and excitation-inhibition balance in the rat neocortex, J Physiol, vol.593, issue.4, pp.825-841, 2015.